{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T07:55:31Z","timestamp":1793778931587,"version":"4.6.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T00:00:00Z","timestamp":1712534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T00:00:00Z","timestamp":1712534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LY22H080004"],"award-info":[{"award-number":["LY22H080004"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017594","name":"Medical Science and Technology Project of Zhejiang Province","doi-asserted-by":"publisher","award":["Project No. 2021KY143"],"award-info":[{"award-number":["Project No. 2021KY143"]}],"id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To explore the prognostic and therapeutic role of Epstein-Barr Virus (EBV) on peripheral T-cell lymphoma (PTCL).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Totally 262 newly diagnosed PTCL patients who were hospitalized from January 2014 to December 2022 were retrospectively enrolled. Molecular analysis included 31 eligible patients. EBV-encoded RNA (EBER) presence in tumor tissue and EBV DNA levels in patients at baseline (DNA1) and after 4 cycles of chemotherapy (DNA4) were assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Our findings revealed that the EBER-positive cohort exhibited significant differences compared to counterparts in overall survival (OS,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.047) and progression-free survival (PFS,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.009). Both DNA1 and DNA4 were significantly associated with inferior OS. Multivariate analysis demonstrated that DNA4 independently affected PTCL prognosis for OS (hazard ratio = 5.1617; 95% confidence interval 1.1017\u201324.1831;\n                      <jats:italic>P<\/jats:italic>\n                      = 0.037). Treatment with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) plus azacytidine regimen showed a better OS compared to CHOP or CHOP plus etoposide for patients with partially positive EBER and EBER positive statuses (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.192), although the improvement was not statistically significant. This study delineated the genetic paradigm of PTCL, comparing genetic differences by EBV status and found that EBER partially positive plus positive patients were more likely to have DNMT3A (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.002), RHOA\n                      <jats:sup>G17V<\/jats:sup>\n                      (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.023), and TET2 mutations (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.032).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>EBER, DNA1, and DNA4 emerged as sensitive markers for prognosis. CHOP plus azacytidine might present a preferable option for PTCL patients with DNA methylation due to EBV infection.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00432-024-05702-9","type":"journal-article","created":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T11:02:12Z","timestamp":1712574132000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Role of plasma EBV-DNA load and EBER status on newly diagnosed peripheral T-cell lymphoma"],"prefix":"10.1007","volume":"150","author":[{"given":"Jing","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghe","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangshu","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enfan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingsong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,8]]},"reference":[{"key":"5702_CR1","doi-asserted-by":"crossref","unstructured":"Abdallah MOE, Algizouli UK, Suliman MA, et al (2018) EBV Associated breast cancer whole methylome analysis reveals viral and developmental enriched pathways. Front Oncol 8","DOI":"10.3389\/fonc.2018.00316"},{"issue":"7","key":"5702_CR2","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","volume":"36","author":"R Alaggio","year":"2022","unstructured":"Alaggio R, Amador C, Anagnostopoulos I et al (2022) The 5th edition of the World Health Organization Classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia 36(7):1720\u20131748","journal-title":"Leukemia"},{"issue":"5","key":"5702_CR3","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1006\/scbi.1999.0137","volume":"9","author":"RF Ambinder","year":"1999","unstructured":"Ambinder RF, Robertson KD, Tao Q (1999) DNA methylation and the Epstein-Barr virus. Semin Cancer Biol 9(5):369\u2013375","journal-title":"Semin Cancer Biol"},{"issue":"2","key":"5702_CR4","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/bjh.19255","volume":"204","author":"K Bednarska","year":"2024","unstructured":"Bednarska K, Chowdhury R, Tobin JWD et al (2024) Epstein-Barr virus-associated lymphomas decoded. Br J Haematol 204(2):415\u2013433","journal-title":"Br J Haematol"},{"issue":"20","key":"5702_CR5","doi-asserted-by":"publisher","first-page":"3652","DOI":"10.1016\/j.cell.2022.08.026","volume":"185","author":"B Damania","year":"2022","unstructured":"Damania B, Kenney SC, Raab-Traub N (2022) Epstein-Barr virus: Biology and clinical disease. Cell 185(20):3652\u20133670","journal-title":"Cell"},{"key":"5702_CR6","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.2147\/OTT.S189825","volume":"12","author":"S Deng","year":"2019","unstructured":"Deng S, Lin S, Shen J, Zeng Y (2019) Comparison of CHOP vs CHOPE for treatment of peripheral T-cell lymphoma: a meta-analysis. Onco Targets Ther 12:2335\u20132342","journal-title":"Onco Targets Ther"},{"issue":"13","key":"5702_CR7","doi-asserted-by":"publisher","first-page":"4163","DOI":"10.1182\/blood-2006-04-017632","volume":"108","author":"J Dupuis","year":"2006","unstructured":"Dupuis J, Emile JF, Mounier N et al (2006) Prognostic significance of Epstein-Barr virus in nodal peripheral T-cell lymphoma, unspecified: a Groupe d\u2019Etude des Lymphomes de l\u2019Adulte (GELA) study. Blood 108(13):4163\u20134169","journal-title":"Blood"},{"issue":"16","key":"5702_CR8","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1182\/blood.2020009004","volume":"137","author":"LMH Falchi","year":"2021","unstructured":"Falchi LMH, Klein S, Lue JK, Montanari F, Marchi E, Deng C, Kim HA, Rada A, Jacob AT, Kinahan C, Francescone MM, Soderquist CR, Park DC, Bhagat G, Nandakumar R, Menezes D, Scotto L, Sokol L, Shustov AR, O\u2019Connor OA (2021) Combined oral 5-azacytidine and romidepsin are highly effective in patients with PTCL: a multicenter phase 2 study. Blood 137(16):2161\u20132170","journal-title":"Blood"},{"issue":"8","key":"5702_CR9","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1002\/ijc.30566","volume":"140","author":"BM Haverkos","year":"2017","unstructured":"Haverkos BM, Huang Y, Gru A et al (2017) Frequency and clinical correlates of elevated plasma Epstein-Barr virus DNA at diagnosis in peripheral T-cell lymphomas. Int J Cancer 140(8):1899\u20131906","journal-title":"Int J Cancer"},{"issue":"9","key":"5702_CR10","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1080\/10245332.2016.1152084","volume":"21","author":"B Jia","year":"2016","unstructured":"Jia B, Hu S, Yang J et al (2016) Comparison of gemcitabin, cisplatin, and dexamethasone (GDP), CHOP, and CHOPE in the first-line treatment of peripheral T-cell lymphomas. Hematology 21(9):536\u2013541","journal-title":"Hematology"},{"key":"5702_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.797028","volume":"11","author":"TY Kim","year":"2021","unstructured":"Kim TY, Min GJ, Jeon YW et al (2021) Impact of Epstein-Barr virus on peripheral T-cell lymphoma not otherwise specified and angioimmunoblastic T-cell lymphoma. Front Oncol 11:797028","journal-title":"Front Oncol"},{"issue":"21","key":"5702_CR12","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1182\/blood-2018-04-840538","volume":"132","author":"F Lemonnier","year":"2018","unstructured":"Lemonnier F, Dupuis J, Sujobert P et al (2018) Treatment with 5-azacytidine induces a sustained response in patients with angioimmunoblastic T-cell lymphoma. Blood 132(21):2305\u20132309","journal-title":"Blood"},{"issue":"3","key":"5702_CR13","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s00280-018-3744-z","volume":"83","author":"X Liu","year":"2018","unstructured":"Liu X, Yang M, Wu M et al (2018) A retrospective study of the CHOP, CHOPE, and CHOPE\/G regimens as the first-line treatment of peripheral T-cell lymphomas. Cancer Chemother Pharmacol 83(3):443\u2013449","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"5702_CR14","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41572-022-00404-3","volume":"8","author":"C Lopez","year":"2022","unstructured":"Lopez C, Burkhardt B, Chan JKC et al (2022) Burkitt Lymphoma. Nat Rev Dis Primers 8(1):78","journal-title":"Nat Rev Dis Primers"},{"key":"5702_CR15","doi-asserted-by":"crossref","unstructured":"Matsusaka K (2014) DNA methylation in gastric cancer, related toHelicobacter pyloriand Epstein-Barr virus. World J Gastroenterol 20(14)","DOI":"10.3748\/wjg.v20.i14.3916"},{"key":"5702_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2021.100889","volume":"52","author":"A Mina","year":"2022","unstructured":"Mina A, Pro B (2022) T time: Emerging and new therapies for peripheral T-cell lymphoma. Blood Rev 52:100889","journal-title":"Blood Rev"},{"issue":"26","key":"5702_CR17","doi-asserted-by":"publisher","first-page":"40025","DOI":"10.18632\/oncotarget.9474","volume":"7","author":"HCY Peng","year":"2016","unstructured":"Peng HCY, Gong P, Cai L, Lyu X, Jiang Q, Wang J, Lu J, Yao K, Liu K, Li J, Li X (2016) Higher methylation intensity induced by EBV LMP1 via NF-\u03baB\/DNMT3b signaling contributes to silencing of PTEN gene. Oncotarget 7(26):40025\u201340037","journal-title":"Oncotarget"},{"issue":"20","key":"5702_CR18","doi-asserted-by":"publisher","first-page":"5195","DOI":"10.1111\/jcmm.17543","volume":"26","author":"L Qiu","year":"2022","unstructured":"Qiu L, Si J, Kang J et al (2022) A retrospective analysis of EBV-DNA status with the prognosis of lymphoma. J Cell Mol Med 26(20):5195\u20135201","journal-title":"J Cell Mol Med"},{"issue":"24","key":"5702_CR19","doi-asserted-by":"publisher","first-page":"5588","DOI":"10.1182\/bloodadvances.2021005171","volume":"5","author":"M Rodr\u00edguez","year":"2021","unstructured":"Rodr\u00edguez M, Alonso-Alonso R, Tom\u00e1s-Roca L et al (2021) Peripheral T-cell lymphoma: molecular profiling recognizes subclasses and identifies prognostic markers. Blood Adv 5(24):5588\u20135598","journal-title":"Blood Adv"},{"issue":"4","key":"5702_CR20","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1002\/hon.2319","volume":"35","author":"C Saillard","year":"2017","unstructured":"Saillard C, Guermouche H, Derrieux C et al (2017) Response to 5-azacytidine in a patient with TET2-mutated angioimmunoblastic T-cell lymphoma and chronic myelomonocytic leukaemia preceded by an EBV-positive large B-cell lymphoma. Hematol Oncol 35(4):864\u2013868","journal-title":"Hematol Oncol"},{"issue":"2","key":"5702_CR21","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/ijc.33802","volume":"150","author":"Z Shen","year":"2022","unstructured":"Shen Z, Hu L, Yao M et al (2022) Disparity analysis and prognostic value of pretreatment whole blood Epstein-Barr virus DNA load and Epstein-Barr encoding region status in lymphomas: a retrospective multicenter study in Huaihai Lymphoma Working Group. Int J Cancer 150(2):327\u2013334","journal-title":"Int J Cancer"},{"issue":"9","key":"5702_CR22","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.jmoldx.2022.06.002","volume":"24","author":"J Song","year":"2022","unstructured":"Song J, Kim JY, Kim S, Park Y (2022) Utility of Epstein-Barr viral load in blood for diagnosing and predicting prognosis of lymphoma: a comparison with Epstein-Barr virus-encoded RNA in situ hybridization. J Mol Diagn 24(9):977\u2013991","journal-title":"J Mol Diagn"},{"issue":"1","key":"5702_CR23","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1159\/000511243","volume":"102","author":"G Usui","year":"2021","unstructured":"Usui G, Matsusaka K, Mano Y et al (2021) DNA methylation and genetic aberrations in gastric cancer. Digestion 102(1):25\u201332","journal-title":"Digestion"},{"issue":"58","key":"5702_CR24","doi-asserted-by":"publisher","first-page":"99104","DOI":"10.18632\/oncotarget.19572","volume":"8","author":"L Wang","year":"2017","unstructured":"Wang L, Wang J-H, Bi X-W, Chen X-Q, Lu Y, Xia Z-J (2017) Interim PET-CT may predict PFS and OS in T-ALL\/LBL adult patients. Oncotarget 8(58):99104\u201399111","journal-title":"Oncotarget"},{"issue":"12","key":"5702_CR25","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.1182\/blood-2010-09-310342","volume":"117","author":"DD Weisenburger","year":"2011","unstructured":"Weisenburger DD, Savage KJ, Harris NL et al (2011) Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project. Blood 117(12):3402\u20133408","journal-title":"Blood"},{"issue":"1","key":"5702_CR26","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/imr.12246","volume":"263","author":"BA Woods","year":"2015","unstructured":"Woods BA, Levine RL (2015) The role of mutations in epigenetic regulators in myeloid malignancies. Immunol Rev 263(1):22\u201335","journal-title":"Immunol Rev"},{"issue":"1","key":"5702_CR27","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s40164-020-00188-w","volume":"9","author":"C Xie","year":"2020","unstructured":"Xie C, Li X, Zeng H, Qian W (2020) Molecular insights into pathogenesis and targeted therapy of peripheral T cell lymphoma. Exp Hematol Oncol 9(1):30","journal-title":"Exp Hematol Oncol"},{"issue":"3","key":"5702_CR28","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.ccell.2020.02.005","volume":"37","author":"J Xiong","year":"2020","unstructured":"Xiong J, Cui BW, Wang N et al (2020) Genomic and transcriptomic characterization of natural killer T cell lymphoma. Cancer Cell 37(3):403-419.e406","journal-title":"Cancer Cell"},{"key":"5702_CR29","unstructured":"Zeng M, Jia Q, Chen J, et al. High plasma EBV-DNA load and positive EBER status associated with viral recurrence and persistent infection in early treatment of lymphoma. Clin Exp Med"},{"key":"5702_CR30","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13045-016-0267-0","volume":"9","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Xu W, Liu H, Li J (2016) Therapeutic options in peripheral T cell lymphoma. J Hematol Oncol 9:37","journal-title":"J Hematol Oncol"},{"issue":"12","key":"5702_CR31","doi-asserted-by":"publisher","first-page":"4413","DOI":"10.1007\/s00253-022-12029-3","volume":"106","author":"L Zhang","year":"2022","unstructured":"Zhang L, Wang R, Xie Z (2022) The roles of DNA methylation on the promotor of the Epstein-Barr virus (EBV) gene and the genome in patients with EBV-associated diseases. Appl Microbiol Biotechnol 106(12):4413\u20134426","journal-title":"Appl Microbiol Biotechnol"},{"issue":"2","key":"5702_CR32","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1159\/000516588","volume":"145","author":"D Zhao","year":"2022","unstructured":"Zhao D, Hu S, Zhou D, Zhang Y, Wang W, Zhang W (2022) Clinical significance of plasma Epstein-Barr virus DNA in peripheral T-cell lymphomas. Acta Haematol 145(2):132\u2013143","journal-title":"Acta Haematol"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-024-05702-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-024-05702-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-024-05702-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T00:04:50Z","timestamp":1716422690000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-024-05702-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,8]]},"references-count":32,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,4]]}},"alternative-id":["5702"],"URL":"https:\/\/doi.org\/10.1007\/s00432-024-05702-9","relation":{},"ISSN":["1432-1335"],"issn-type":[{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,8]]},"assertion":[{"value":"7 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"This article does not include the patients' names, portrait and other private information. Informed consent was obtained from the patients or their relatives for publication of this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}],"article-number":"181"}}